We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies.
Scrip is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183
Series A brings in $4.6mm for three-year-old Airway Therapeutics
11 Sep 2014
Executive Summary
Pulmonary disease-focused Airway Therapeutics LLC raised $4.6mm in its Series A financing led by CincyTech, which was joined by Cincinnati Children's Hospital Medical Center (from which the company licensed IP to begin operations), Queen City Angels, and private investors. Proceeds will support ongoing development of AT100, a recombinant protein in preclinical studies for bronchopulmonary dysplasia. The firm raised $500k in its June 2011 seed round.
Deal Industry
Pharmaceuticals
Biotechnology
Large Molecule
Deal Status
Final
Deal Type
Financing
Venture Financing
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?